Zydus Lifesciences Company Profile

What is the competitive landscape for ZYDUS LIFESCIENCES, and what generic alternatives to ZYDUS LIFESCIENCES drugs are available?

ZYDUS LIFESCIENCES has sixty-seven approved drugs.

There is one US patent protecting ZYDUS LIFESCIENCES drugs.

There are four patent family members on ZYDUS LIFESCIENCES drugs in four countries and one hundred and sixty-two supplementary protection certificates in sixteen countries.

Summary for Zydus Lifesciences

International Patents:	4
US Patents:	1
Tradenames:	58
Ingredients:	58
NDAs:	67

Drugs and US Patents for Zydus Lifesciences

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Zydus Lifesciences	ACYCLOVIR	acyclovir	OINTMENT;TOPICAL	205974-001	Mar 15, 2019	AB	RX	No	No
Zydus Lifesciences	ZITUVIO	sitagliptin	TABLET;ORAL	211566-003	Oct 18, 2023		RX	Yes	Yes	10,925,871		Y
Zydus Lifesciences	CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE	candesartan cilexetil; hydrochlorothiazide	TABLET;ORAL	203466-001	Nov 27, 2017	AB	RX	No	No
Zydus Lifesciences	NYSTATIN AND TRIAMCINOLONE ACETONIDE	nystatin; triamcinolone acetonide	OINTMENT;TOPICAL	207764-001	Nov 8, 2018	AT	RX	No	No
Zydus Lifesciences	ROPINIROLE HYDROCHLORIDE	ropinirole hydrochloride	TABLET;ORAL	090411-007	Jun 1, 2009	AB	RX	No	No
Zydus Lifesciences	PROPAFENONE HYDROCHLORIDE	propafenone hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	214184-003	Apr 21, 2021	AB	RX	No	No

International Patents for Zydus Lifesciences Drugs

Country	Patent Number	Estimated Expiration
World Intellectual Property Organization (WIPO)	2015128877
South Africa	201606075
India	651MU2014
Philippines	12016501686

Supplementary Protection Certificates for Zydus Lifesciences Drugs

Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
0459136	98C0016	Belgium		PRODUCT NAME: CANDESARTAN CILEXETIL; NAT. REGISTRATION NO/DATE: 212 IS 236 F3 19980119; FIRST REGISTRATION: GB PL 15661/0001 19970429
1412357	C 2007 091	Romania		PRODUCT NAME: (3R)-3-AMINO-1-[9-(TRIFLUOROMETIL)-1,4,7,8-TETRAZABICICLO[4.3.0]NONA-6,8-DIEN-4-IL]-4-(2,4,5-TRIFLUOROFENIL)BUTAN-1-ONA - SITAGLIPTIN; NATIONAL AUTHORISATION NUMBER: RO EU/1/07/383/001 - RO EU/1/07/383/018; DATE OF NATIONAL AUTHORISATION: 20070321; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): EU/1/07/383/001 - EU/1/07/383/018; DATE OF FIRST AUTHORISATION IN EEA: 20070321
1304992	92401	Luxembourg		PRODUCT NAME: CLINDAMYCINE(EN TANT QUE PHOPSHATE DE CLINDAMYCINE)ET TRETINOINE
1532149	92128	Luxembourg		PRODUCT NAME: 8-(3-AMINOPIPERIDIN-1-YL)-7-BUT-2-INYL-3-METHYL-1-(4-METHYLCHINAZOLIN-2-YLMETHYL)-3, 7-DIHYDROPURIN-2, 6-DION, LES ENANTIOMERES ET LEURS SELS, EN PARTICULIER LA LINAGLIPTINE COMBINEE AVEC DU CHLORHYDRATE DE METFORMINE. LINAGLIPTINE
1534313	2015/071	Ireland		PRODUCT NAME: AN OCULAR IRRIGATION SOLUTION COMPRISING PHENYLEPHRINE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND KETOROLAC OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF; REGISTRATION NO/DATE: EU/1/15/1018 20150728
1412357	C200700039	Spain		PRODUCT NAME: SITAGLIPTINA; NATIONAL AUTHORISATION NUMBER: EU/1/07/383/001-018; DATE OF AUTHORISATION: 20070321; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): EU/1/07/383/001-018; DATE OF FIRST AUTHORISATION IN EEA: 20070321

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Zydus
• Zydus Hlthcare
• Zydus Lifesciences
• Zydus Noveltech Inc
• Zydus Pharms
• Zydus Pharms Usa